Neurodegenerative diseases

The case of the sticky protein

Proteins are like a body’s in-house Lego set. These large, complex molecules are made up of building blocks called amino acids. Most of the time, proteins fold correctly, but sometimes they can misfold. This misfolding causes the proteins to get sticky, and that can promote clumping, or aggregation, which is the hallmark of several neurodegenerative diseases such as ALS, Alzheimer’s and Parkinson’s.

Ashutosh Tiwari and his doctoral student Nethaniah Dorh work on misfolded...
Ashutosh Tiwari and his doctoral student Nethaniah Dorh work on misfolded proteins. They collaborated with synthetic chemists and physicists to better understand a BODIPY-based probe to test protein stickiness, a precursor to some neurodegenerative diseases.
Source: Michigan Tech/Sarah Bird

The protein’s stickiness is a result of surface hydrophobic interactions that are important for many biological functions. The problem is that researchers don’t have good tools to measure this stickiness with high sensitivity.

Now, an interdisciplinary team at Michigan Technological University has assembled new tools to solve the case of the sticky protein. Their work on improving hydrophobicity detection using BODIPY-based probes will be published in Scientific Reports.

Using fluorescent probes, the team measured hydrophobicity in three proteins: Bovine Serum Albumin (BSA), apomyoglobin and myoglobin. Compared to a commonly used commercial sensor (ANS), these new BODIPY-based hydrophobic sensors showed much stronger signal strengths, with up to a 60-fold increase in BSA.

“This is like going from having one 40-watt light bulb and then having 60 of them in the same room, just imagine the difference in illumination,” says Ashutosh Tiwari, an associate professor of chemistry at Michigan Tech and the corresponding author for the study.


Source: Michigan Technological University

07.01.2016

More on the subject:

Related articles

Photo

Article • Promising, but in need of further validation

Implementation challenges of blood biomarkers for Alzheimer’s disease

Blood-based biomarker (BBB) tests may represent the best weapon to combat the soaring rates of Alzheimer’s disease (AD) throughout the world. Existing clinically validated tests are currently…

Photo

News • Study explores impact

How brain trauma can trigger Alzheimer's disease

Traumatic brain injury (TBI) increases dementia risk, but the reasons are poorly understood. Now, a study explores the role of the brain's blood vessels as drivers of Alzheimer's disease.

Photo

News • Exploring the neurovascular unit (NVU)

Promising new approach to detecting Alzheimer's

Research suggests a new approach to detecting Alzheimer’s disease: changes in brain oxygenation dynamics and neuronal function contribute to the neurodegeneration.

Related products

Subscribe to Newsletter